Cancer Immunotherapy

The field of Cancer Immunotherapy is of continuously escalating significance, as well as scientifically, economically and socially important. The Cancer Immunotherapy Conference on November 7-8, 2016 in San Francisco, CA allows scientists, clinicians, and R&D experts to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field.

 

The immune system plays a central role not only in fighting infections, but also in many other diseases and medical conditions including cancer. The study of the immune system has lead to significant findings in many fields of medicine and biology and has resulted in the discovery of novel and unique substances and reagents that are now widely used for diagnosis, evaluation and therapy of different malignant diseases. The development of prophylactic and therapeutic vaccines, as well as innovative combinatorial immunotherapeutic approaches for patients with cancer has substantially decreased mortality and morbidity and improved the life, life expectancy, and the well being of the millions of patients with malignant diseases.

We hope to see you there

POSTER SUBMISSIONS:
GTCbio encourages attendees to gain exposure by presenting their work in the poster sessions. Your research will be seen by leaders from top pharmaceutical, biotech, academic and government institutions, and will also be published in the conference materials. The top 2-3 qualified submitted abstracts will also be selected by the meeting's scientific advisory board for the chance to give a short oral presentation in the conference program.

Deadline to submit abstracts for poster presentations: October 7, 2016
Click here (https://www.gtcbio.com/submit-an-abstract/cancer-immunotherapy) to submit an abstract.Complete all fields. Maximum number of words is 250 and maximum number of characters is 2,500. If possible, attach a document (.doc, .docx, or .pdf) should your abstract exceed the maximum number of words.

Deadline to register and secure your poster board slot: October 24, 2016
Please note that submitting your abstract does NOT guarantee you a poster board at the meeting. GTCbio reserves poster boards based on the number of delegates whose abstracts have been approved and have registered and paid in full for the conference. Any abstracts submitted after the registration deadline will not be guaranteed a poster board.
Important Notes:

1. You will be notified by the conference organizers via email as soon as your submission has been reviewed.
2. Posters accepted by the deadline will be considered for oral presentation one month prior to the conference.
3. Posters submitted after the deadline will be considered for poster presentation only.
4. Oral presentation winners will be notified via email or telephone 2-3 weeks before the conference.
5. Selected oral presenters will be posted on the agenda.
6. You must be registered for the conference to present at the poster session.
7. Conference program posters must be relevant to the main conference topics.
POSTER SIZE AND SET UP:
Poster boards are 4 feet in width by 6 feet in height. (122 cm by 182 cm). Posters should be portrait orientation, with maximum dimensions to fit on the board accordingly. If accepted for the poster session, an email will be sent with details on when and where to pin your poster. Pins will be provided.
* GTCbio reserves the right to publish your poster title and abstract in various marketing materials and products.
ABOUT GTCBIO

GTCbio is a leading information center that provides quality forums, which facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. Our conferences cover a variety of topics, such as stem cell therapeutics, infectious diseases, biotech partnering, pharmaceutical litigation, government regulation, bio-based chemicals and many more. Founded in 2002, GTCbio stimulates scientific discussions, offers key business insights, and promotes partnering and deal-making in the ever-changing biotech and pharmaceutical world.

Others Details

VISIT: https://www.gtcbio.com/conferences/cancer-immunotherapy-overview